Verastem, Inc. (VSTM)
6.33
+0.19
(+3.09%)
USD |
NASDAQ |
Apr 15, 16:00
6.325
0.00 (0.00%)
After-Hours: 20:00
Verastem Research and Development Expense (Annual) : 114.60M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 14.83B |
| Merck & Co., Inc. | 12.51B |
| Altimmune, Inc. | 66.32M |
| Ocugen, Inc. | 37.36M |
| Xilio Therapeutics, Inc. | 56.04M |